Glaucoma Screening
Completed · Not applicable
Conditions studied: Glaucoma
In brief
* The primary objective of this study is to evaluate the diagnostic accuracy of the TEMPO (iMOvifa) visual field perimeter screening test by measuring the sensitivity in a population of eyes with glaucoma and the specificity in a population of normal eyes and to measure repeatability of the screening test. * The secondary objective of this study is to gather and analyze ancillary data to confirm the diagnosis or absence of glaucoma.
Key facts
- Study ID
- NCT06186388
- Run by
- Cape Fear Eye Institute
- People needed
- 200
- Starts
- 2023-12-05
- Expected to finish
- 2024-05-15
- Last updated by the study team
- 2024-08-26
Who can join
Age: 40 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Cape Fear Eye Institute — Wilmington, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.